Search Now

Recommendations

Showing posts with label Piramal Healthcare. Show all posts
Showing posts with label Piramal Healthcare. Show all posts

Tuesday, August 02, 2011

Piramal Healthcare Q1 cons net profit at Rs89 cr


Piramal Healthcare has announced the following results for the quarter ended June 30, 2011

Standalone Results

The Unaudited results for the Quarter ended June 30, 2011

The net profit of the company stood at Rs101.09 crore for the quarter ended June 30, 2011 whereas the same was at Rs66.91 crore for the quarter ended June 30, 2010.

The total income of the company came in Rs334.83 crore for the quarter ended June 30, 2011 whereas the same was at Rs599.73 crore for the quarter ended June 30, 2010.

Consolidated Results

The Unaudited consolidated results for the Quarter ended June 30, 2011

The net profit of the group came in Rs89.23 crore for the quarter ended June 30, 2011 whereas the same was at Rs80.74 crore for the quarter ended June 30, 2010.

The total income of the group stood at Rs511.96 crore for the quarter ended June 30, 2011 whereas the same was at Rs866.22 crore for the quarter ended June 30, 2010.
The figures for the quarter ended June 30, 2011 are not comparable to the previous quarter on account of the sale of Domestic formulation business and Diagnostics Services.

Piramal Healthcare closed at Rs380.65, down by 0.31%, with a volume of 0.26 lakh shares on the BSE

Sunday, October 31, 2010

Piramal Healthcare Ltd


Shareholders can remain invested in the stock of Piramal Healthcare in the near-term. With its key cash cow sold to Abbott Labs, the stock's current valuations largely take support from the cash value on its books.

Sunday, June 27, 2010

Annual Report - Piramal Healthcare - 2009-2010


PIRAMAL HEALTHCARE LIMITED

ANNUAL REPORT 2009-2010

DIRECTOR'S REPORT

Dear Shareholders,

We take pleasure in presenting the 63rd Annual Report and Audited Accounts
for the Year ended 31st March 2010.